Cuál es el precio por RepliCel Life Sciences Inc. (RP)

Precio por RepliCel Life Sciences Inc. (RP) es de$0.01100905

Cuál es la capitalización de mercado por RepliCel Life Sciences Inc. (RP)

Capitalización de mercado por RepliCel Life Sciences Inc. (RP) es $810.02K

RepliCel Life Sciences Inc. (RP) Precio y Capitalización de Mercado

Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.

Precio por RP	Activo B	Capital del mercado en B	Resultados
$74,159.69 $810.02K	NVDA	$5.457T	+673,624,491.71%
$60,932.35 $810.02K	AAPL	$4.483T	+553,474,847.43%
$56,558.66 $810.02K	GOOG	$4.161T	+513,746,689.53%
$50,106.80 $810.02K	MSFT	$3.687T	+455,141,709.98%
$38,525.25 $810.02K	AMZN	$2.835T	+349,941,467.77%

Precio por RP

Activo B

Capital del mercado en B

Resultados

$74,159.69 $810.02K